1. 1
   META Strong Add A / A / A− · PEG 0.89 · entry $580–630 · in zone

   Cleanest large-cap setup. 20× fwd P/E, +33% YoY rev, ad impressions +19% × price-per-ad +12% — both volume and price compound simultaneously. Capex-anxiety obscures that core monetisation is accelerating. Current ~$596, mid-zone ($580–630). No earnings until late Jul — lowest-event-risk Strong Add in the universe.
2. 2
   CRM Strong Add B+ / A− / A · PEG 0.86 · entry $160–205 · in zone

   13.6× fwd P/E for an enterprise SaaS leader is a value setup masquerading as software. Agentforce $800M ARR (+169% YoY) is income-statement revenue, not pipeline. Q1 FY27 reported (27 May) — update ticker page for results. Dim 1 capped at B+ until organic growth re-acceleration (FY27 H2 guide) is confirmed. Asymmetric: Agentforce traction = rerating; disappointment = own a $146B FCF compounder at 11× EV/FCF.
3. 3
   AVGO Strong Add A / A / A− · PEG ~0.53 · entry $370–400 · ~$397 · in zone

   Q2 FY26 (3 Jun) was a clean beat-and-raise — revenue $22.19B, AI semis $10.8B (+143%), record 46% FCF margin, software back to +9%, Q3 guided $29.4B above Street, networking at 40% of AI revenue, AI bookings >$30B vs $10.8B shipped. The stock fell ~15% to ~$397 purely because Hock Tan reiterated rather than raised the FY27 $100B chip target — handing the pullback the prior verdict was waiting for. Now in the $370–400 zone with Dim 2 upgraded to A and Dim 3 to A−. Add toward 6–8% here; reserve further adds for <$370.
4. 4
   NOW Hold · Stage <$90 A / A / A− · PEG 0.83 · entry $80–95 · in zone

   A/A/A− on three dimensions — best-balanced grade card in the table. Q1 reported (late May) — update ticker page for results. Entry zone $80–95 remains; target below $90 for re-entry or add. Pro Plus ACV attach + Federal renewal pacing are the two metrics that confirm the FY27 thesis.
5. 5
   TSM Add (pullback) A / A / B− · PEG 0.53 · entry $340–375 · ~9% above

   Foundry monopoly on leading-edge nodes — Apple, NVDA, AMD anchored, 59% HPC mix. +41% rev growth at PEG 0.53 is the cheapest scale-vs-multiple combination in the table. ~$410 sits ~9% above zone; per the SKILL.md quality override, Dim 1 A justifies staged starter now (3–5%) with discipline to add to target weight only on retest of $375 or post-Q2 (16 Jul) print dip.

• !AI cohort hit record highs week of 8 May. Cohort drawdowns of 15–20% historically follow record-print weeks. Stage entries over 6–8 weeks; never lump-sum at the top.
• !Memory cycle may run longer than expected — but margins revert. SNDK Q3 FY26 management confirmed NAND market "more undersupplied in Q3 than Q2," with demand above supply through CY2026. SNDK upgraded to Add (pullback); MU remains Hold. Do not add both simultaneously — combined memory exposure would exceed prudent cycle-risk limits. Cyclical margin reversion is when-not-if: NAND GMs compressed from ~65% peak to 25–35% in the 2022–23 downcycle.
• !Pre-earnings asymmetry is bad. NVDA (20 May), CRM (27 May), and AVGO (3 Jun) have printed. Remaining: MU (24 Jun), hyperscalers (late Jul), AAOI (6 Aug) carry 8–12% implied moves. Resist adding inside the 5-day pre-print window — better risk/reward post-print, off the gap.
• !Concentration is a hidden risk. Closing the active-picks gap by adding two more software names creates correlated AI-capex exposure. Spread across foundry / optics / software / power.
• !Insider clusters worth respecting. PLTR insiders sold $432.9M in 90 days incl. Thiel 1.9M shares (position exited). AAOI insider selling $29.6M / 90d. AVGO Hock Tan 200K shares sold/contributed since Dec. Treat as a hard signal, not noise.
• !"In entry zone" ≠ "must buy now." The zone is permission, not obligation. If Dim 1 + Dim 2 + macro all line up, take it. If two of three are weak, wait for confirmation. Per SKILL.md quality override, Dim 1 A/A+ names above zone get a 3–5% starter — not a full skip.
• !Single-stock cap 20%. Hard rule. MU is the closest current breach risk — let it run, but the next add goes elsewhere.

• ✗Add more MU above $1,000. Currently ~$985, well above prior $600–650 entry zone — has blown through the $850–900 trim trigger. Consider trimming incrementally above $1,000 to bank gains and manage cyclical-reversion risk. HBM tailwind is real but margin reversion is when-not-if. 24 Jun Q3 print is the next definitive signal.
• ⚠Re-enter PLTR without a margin of safety. Position exited; three risk vectors remain — 88× fwd P/E, $432.9M insider sales 90d (incl. Thiel 1.9M shares), and Anthropic's $1.5B enterprise-services JV as direct competition. Multiple-compression to ~$90 is a live scenario. Re-entry at $100–115 or below makes the math work; chasing above $130+ does not. 4 Aug Q2 print is the next re-evaluation gate.
• ✗Chase NVDA above $235 (top of entry zone). Q1 FY27 reported (20 May); entry zone updated to $210–235. Currently ~$210, near zone bottom — a better entry point than the pre-print $220 level. Add within $210–225; resist chasing above $235 ahead of Q2 FY27.
• ✗Treat NEE as an AI growth story. It's a utility with AI optionality at PEG 3.1. Add only for income and power hedge, not AI growth.
• ✗Add SNDK at market after the Q3 FY26 run-up. Q3 beat consensus by 29% ($5.95B actual vs $4.6B guide midpoint); Q4 guided $7.75–8.25B — well above prior Dec 2027 consensus of $4.19B. Verdict upgraded to Add (pullback). Wait for $1,200–1,350 zone before initiating. Stacking with MU creates correlated NAND/DRAM memory cyclicality — size ≤5% NLV on any entry.
• ✗Add AAOI before 6 Aug Q2 print. Currently ~$203, up +29% since last review — now 45% above the $120–140 entry zone. Insider selling $29.6M / 90d, Q1 slight miss ($151M vs $155M est), Texas fab ramp unvalidated. Q2 on 6 Aug is the gate; entry zone $120–140 only post-confirmation.
• ✗Deploy all capital at once. AI cohort hit record highs week of 8 May. Stage over 6–8 weeks.
• ✗Add Bloom Energy (BE) at ~$301. Never GAAP-profitable, ~135× fwd P/E, PEG 3.37. AI fuel cell thesis aspirational not demonstrated. Entry zone $180–220 (~40% below current).
• ✗Add ARM at current price ($213+). PEG 4.87 — worst in the AI-chip basket. 11.46% short interest. NVDA at 26.5× / PEG 0.35 is a strictly better AI chip bet.
• ✗Chase AMD above $420. Currently ~$436, pulling back from $460 high — approaching zone but not yet there. Meta 6GW and OpenAI MI450 commitments are real but priced in. Wait for $380–420 zone before initiating.

• ValuationIn-zone names: AVGO (~$401/$370–400), META (~$596/$580–630), CRM (~$179/$160–205), NVDA (~$210/$210–235), NEE (~$84/$82–88). PEGs 0.53–0.89 on core positions. DDOG (~$199) above its zone — quality override permits 3–5% starters only.
• Above zoneTSM, COHR, GEV, AMD, ALAB, SNDK, MU (~$985, 50%+ above zone), BE, DDOG, AAOI (~$203), GOOGL (~$365) all above entry zones. NBIS initiated after CapEx confirmation.
• SentimentActive picks now ~46.6% (near 50% target). Cash ~18.8%. Remaining deployment should be selective — wait for dips in held names or new thesis-breaking events.
• EventsNVDA, CRM, AVGO Q prints all done. Upcoming: MU 24 Jun (cyclical-margin signal), hyperscalers late Jul, AAOI 6 Aug. Reserve remaining dry powder for post-MU reaction and hyperscaler gap-down opportunities.

Active picks now ~46.6% — near the 50% target. Remaining ~18% cash provides a buffer for post-MU-print positioning (24 Jun), hyperscaler down-gaps (late Jul), and any tail risk. Below 15%: too tight given MU cyclical-reversion risk and upcoming catalysts. Above 22%: opportunity cost at ~6% per quarter is meaningful when in-zone names like META, AVGO, NVDA, and CRM are available now.

• ↓S&P drawdown >7% from 8 May high → accelerate deployment to ~10% cash.
• ↓Held name retests support post-earnings (MU post-24 Jun print dip, NVDA $210, META $580, AVGO $370, GOOGL $340) → redirect dry powder into the dip.
• ↑VIX >25 sustained or two of (NVDA, CRM, AVGO, MU, META) miss → step back to 20–25% cash, wait for clarity.
• ↑MU 24 Jun signals margin peak or forward guide cut → trim MU above $1,000, raise cash 3–5pp. Also consider trimming SIMO on same print.